Replies to post #158196 on Biotech Values

[dav1234]

Those damn generics...lol..in 7.10 for a boing

[acgood]

LOL re SPPI's excuse for the shortfall (generic competition).

Huh? In this case, it is the actual reason. SPPI has bogusly been claiming that their market share gains during the leocovorin shortage were "sticky" and would not reverse when generics became widely available. Today they are admitting reality, not making an excuse.

What they need an excuse for is guiding for 300+ million in 2013 revenue 3 weeks ago but 160-180m today